Last quarter (Q4 2023), Sarepta Therapeutics's total revenue was $396.78M, an increase of 68.15% from the same quarter last year. In Q4, Sarepta Therapeutics's net income was $-43.22M. See Sarepta Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 1.24B	$ 1.24B	$ 933.01M	$ 612.40M	$ 540.10M	$ 380.83M
Cost of Revenue	$ -150.34M	$ -150.34M	$ -139.99M	$ 107.05M	$ 63.38M	$ 56.59M
Gross Profit	$ 1.35B	$ 1.39B	$ 793.02M	$ 505.35M	$ 476.72M	$ 324.25M
Operating Expense	$ 1.41B	$ 1.36B	$ 1.33B	$ 1.05B	$ 1.04B	$ 846.57M
Operating Income	$ -290.64M	$ -267.82M	$ -536.20M	$ -549.19M	$ -564.16M	$ -522.32M
Net Non Operating Interest Income Expense	$ 26.89M	$ 14.25M	$ -36.76M	$ 7.20M	$ -56.98M	$ -23.43M
Other Income Expense	$ 155.06M	$ 153.81M	$ 117.00M	$ -123.05M	$ 68.08M	$ -168.13M
Pretax Income	$ -520.10M	$ -520.10M	$ -689.96M	$ -418.94M	$ -553.07M	$ -713.88M
Tax Provision	$ 15.88M	$ 15.88M	$ 13.53M	$ -168.00K	$ 1.06M	$ 1.20M
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -602.15M	$ -535.98M	$ -703.49M	$ -418.77M	$ -554.13M	$ -715.08M
Basic EPS	$ -6.15	$ -5.80	$ -8.03	$ -5.15	$ -7.11	$ -9.71
Diluted EPS	$ -6.15	$ -5.80	$ -8.03	$ -5.15	$ -7.11	$ -9.71
Basic Average Shares	$ 369.59M	$ 92.40M	$ 87.56M	$ 81.26M	$ 77.96M	$ 73.61M
Diluted Average Shares	$ 369.59M	$ 92.40M	$ 87.56M	$ 81.26M	$ 77.96M	$ 73.61M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 1.26B	$ 1.21B	$ 1.19B	$ 1.16B	$ 1.10B	$ 903.16M
Net Income From Continuing And Discontinued Operation	$ -535.98M	$ -535.98M	$ -703.49M	$ -418.77M	$ -554.13M	$ -715.08M
Normalized Income	$ -73.70M	$ -379.94M	$ -542.50M	-	$ -600.17M	$ -581.31M
Interest Expense	-	-	-	-	$ 59.95M	$ 30.67M
EBIT	$ -510.73M	$ -498.09M	$ -636.72M	$ -482.47M	$ -493.12M	$ -683.21M
EBITDA	$ -466.34M	$ -453.69M	$ -594.85M	$ -444.45M	$ -466.21M	$ -658.71M

Currency in USD

Sarepta Therapeutics Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing